Ardelyx (ARDX) Property, Plant & Equipment (Net) Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.67% |
| Dec 31, 2025 | 2.44% |
| Sep 30, 2025 | -0.40% |
| Jun 30, 2025 | -3.04% |
| Mar 31, 2025 | -10.92% |
| Dec 31, 2024 | -15.33% |
| Sep 30, 2024 | -23.58% |
| Jun 30, 2024 | -25.64% |
| Mar 31, 2024 | -27.54% |
| Dec 31, 2023 | -29.05% |
| Sep 30, 2023 | -28.56% |
| Jun 30, 2023 | -30.77% |
| Mar 31, 2023 | -31.60% |
| Dec 31, 2022 | -31.37% |
| Sep 30, 2022 | -31.57% |
| Jun 30, 2022 | -30.25% |
| Mar 31, 2022 | -25.51% |
| Dec 31, 2021 | -23.46% |
| Sep 30, 2021 | -17.58% |
| Jun 30, 2021 | -11.20% |
| Mar 31, 2021 | -12.99% |
| Dec 31, 2020 | -16.29% |
| Sep 30, 2020 | -13.63% |
| Jun 30, 2020 | -9.24% |
| Mar 31, 2020 | -2.03% |
| Dec 31, 2019 | 10.03% |
| Sep 30, 2019 | 27.90% |
| Jun 30, 2019 | 31.47% |
| Dec 31, 2018 | 60.31% |